BesslerM, DaudA, DiGiorgiMF, SchropeBA, InabnetWB, DavisDG. Frequency distribution of weight loss percentage after gastric bypass and adjustable gastric banding. Surg Obes Relat Dis, 2008; 4:486–491.
2.
US Food and Drug Administration, Center for Devices and Radiological Health. LAP-BAND Adjustable Gastric Banding (LAGB) System—P000008.
3.
BrownSL, ReidMH, DuggiralaHJ. Adjustable silicone gastric banding adverse events reported to the Food and Drug Administration. J Long Term Eff Med Implants, 2003; 13:509–517.
SuterM, CalmesJM, ParozA, GiusiV. A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg, 2006; 16:829–835.
7.
GagnerM, MiloneL, TrellesN. Mortality after laparoscopic adjustable gastric banding: results from an anonymous questionnaire to ASBS members. Obes Surg, 2009; 19:1567–1663.
8.
BierthoL, SteffenR, RicklinT, HorberFF, PompA, InabnetWB, HerronD, GagnerM. Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding: a comparative study of 1,200 cases. J Am Coll Surg, 2003; 197:536–544.
9.
DixonJB, O'BrienPE, PlayfairJ, ChapmanL, SchachterLM, SkinnerS, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA, 2008; 299:316–323.
10.
SchauerPR, KashyapSR, WolskiK, BrethauerSA, KirwanJP, PothierCE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med, 2012; 366:1567–1576.
11.
GagnerM. Gastric banding: conversion to sleeve, bypass, or DS. Surg Endosc, 2007; 21:1931–1935.
12.
NguyenNT. A prospective randomized trial of laparoscopic gastric bypass versus lapasroscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg, 2009; 250:631–641.
13.
BuchwaldH, OienDM. Metabolic/bariatric surgery worldwide 2011. Obes Surg, 2013; 23:427–436.
14.
O'BrienPE, DixonJB, LaurieC, SkinnerS, ProiettoJ, McNeilJ, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med, 2006; 144:625–633.
15.
O'BrienPE, BrennanL, LaurieC, BrownW. Intensive medical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomized trial. Obes Surg, 2013; 23:1345–1353.
16.
O'BrienPE, MacDonaldL, AndersonM, BrennanL, BrownWA. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systemic review of the bariatric surgical literature. Ann Surg, 2013; 257:87–94.
17.
DixonJB, O'BrienPE, PlayfairJ, ChapmanL, SchachterLM, SkinnerS, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA, 2008; 299:316–323.
18.
SchauerPR, KashyapSR, WolskiK, BrethauerSA, KirwanJP, PothierCE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med, 2012; 366:1567–1576.
19.
MingroneG, PanunziS, De GaetanoA, GuidoneC, IaconelliA, LeccesiL, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med, 2012; 366:1577–1585.
20.
IkramuddinS, KornerJ, LeeWJ, ConnettJE, InabnetWB, BillingtonCJ, et al. Roux-en-Y gastric bypass vs. intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA, 2013; 309:2240–2249.
21.
ZimmetP, AlbertiKGMM. Surgery or medical therapy for patients with type 2 diabetes?. N Engl J Med, 2012; 366:1635–1636.
